Analysts at StockNews.com began coverage on shares of Blonder Tongue Laboratories (NYSE:BDR – Get Rating) in a research note issued on Wednesday. The firm set a “hold” rating on the stock.
Blonder Tongue Laboratories Stock Performance
Blonder Tongue Laboratories has a 12 month low of $0.28 and a 12 month high of $1.91.
Blonder Tongue Laboratories Company Profile
Want More Great Investing Ideas?
- Get a free copy of the StockNews.com research report on Blonder Tongue Laboratories (BDR)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Blonder Tongue Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blonder Tongue Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.